CHMP Positive On Pfizer's Adalimumab

As Accord Gets Nods For Azacitidine And Dexmedetomidine

 
• By David Wallace
  
Pfizer
Pfizer has received a CHMP nod for its Amsparity full-label adalimumab biosimilar rival to Humira • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products